Clinical Trial Update: Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating bicalutamide with or without enzastaurin for prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN